We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (232)
- COVID-19 (55)
- Compliance and enforcement (45)
- Vaping hub (33)
- Import and export (20)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (10)
- Legislation (7)
- Weight loss products (6)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
517 result(s) found, displaying 426 to 450
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
Media releasesThe TGA has released the findings of its review into breast implants and breast tissue expanders
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
Media releasesInformation on how supplements are regulated in Australia
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure
-
Media releasesThe TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia
-
Media releasesThe TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy
-
Media releasesThe 2019 TGA stakeholder survey is open. Have your say before 5 July
-
Media releasesWe're encouraging all Australians to return their unused opioids to their local pharmacy
-
Media releasesInternational work-sharing initiative approves Niraparib (Zejula®)
-
Media releasesReasons for releasing guidance and how it was developed
-
Media releasesOn Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney
-
Media releasesThe TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches